Erste Asset Management Gmb H Biomarin Pharmaceutical Inc Transaction History
Erste Asset Management Gmb H
- $11.9 Trillion
- Q2 2025
A detailed history of Erste Asset Management Gmb H transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Erste Asset Management Gmb H holds 48,796 shares of BMRN stock, worth $2.77 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
48,796
Previous 50,688
3.73%
Holding current value
$2.77 Million
Previous $3.52 Billion
23.47%
% of portfolio
0.02%
Previous 0.05%
Shares
26 transactions
Others Institutions Holding BMRN
# of Institutions
674Shares Held
183MCall Options Held
1.23MPut Options Held
1.11M-
Black Rock Inc. New York, NY22.7MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.08 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$897 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$859 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$699 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...